Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1
Condition: Niemann-Pick Disease, Type C1 Intervention: Drug: Hydroxypropyl-beta-cyclodextrin Sponsor: CTD Holdings, Inc. Not yet recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials